Skip to main content

Security report for astrazeneca-us.com

AstraZeneca · Healthcare · United States

Low risk. 2 critical or high findings in Security headers and SSL/TLS.

Security score

78/100

Risk levelLow

0–100, higher is better. How it is calculated

AstraZeneca US operates as a major biopharmaceutical company focusing on delivering innovative medicines primarily in oncology and biopharmaceuticals. The website reflects a mature digital presence with comprehensive content targeting patients, healthcare providers, and other stakeholders. The technical infrastructure leverages modern web technologies, including Adobe Experience Manager CMS, AWS hosting, and advanced analytics tools such as Adobe Analytics and Tealium. The site is well-optimized for mobile and accessibility, with clear navigation and professional branding. From a security perspective, the website enforces HTTPS and employs cookie consent mechanisms, indicating compliance with privacy regulations such as GDPR. While explicit security headers were not fully confirmed, the use of reputable third-party services and absence of exposed sensitive data suggest a strong security posture. The lack of WHOIS data limits domain registration verification, but the overall trust signals and branding consistency support legitimacy. Overall, AstraZeneca US demonstrates a robust digital and security posture suitable for a large healthcare enterprise. Strategic improvements could focus on enhancing transparency around security policies and incident response, as well as verifying and publishing vulnerability disclosure information.

Scanned

NIS2 and GDPR posture

GDPR outside view
83/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching astrazeneca-us.com

This scan found 18 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
82
Security headers
50
Email security
70
DNS health
85
Network security
100
GDPR outside view
83
Average
78

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

AstraZeneca US holds a strong market position as a global leader in healthcare and pharmaceuticals, with a focus on oncology and biopharmaceuticals. The business model centers on research, development, and commercialization of prescription medicines. The website targets a broad audience including patients, caregivers, healthcare providers, and investors. The company leverages partnerships with technology providers such as AWS, Adobe, and Tealium to support its digital operations. Growth indicators include active media presence, community impact initiatives, and patient support programs. The site reflects a mature partnership ecosystem and strategic focus on innovation and patient care.

Security posture

The security posture of AstraZeneca US's website is strong, with HTTPS enforced and cookie consent mechanisms in place. The use of established analytics and tag management platforms reduces risk from third-party scripts. No critical vulnerabilities or exposed sensitive data were detected in the HTML content. However, explicit security headers such as X-Frame-Options and X-Content-Type-Options were not confirmed and should be audited. There is no publicly visible incident response or vulnerability disclosure policy, which could be improved to enhance security culture and transparency. Overall, the site aligns well with industry best practices for security and privacy compliance.

Recommendations

  1. Conduct a security header audit and implement missing headers like X-Frame-Options and X-Content-Type-Options.
  2. Publish a clear incident response and vulnerability disclosure policy to improve transparency and security culture.
  3. Regularly review and update third-party scripts and analytics tools to mitigate potential vulnerabilities.
  4. Enhance visibility of data protection officer contact information to support GDPR compliance.
  5. Implement continuous monitoring and penetration testing to proactively identify and remediate security risks.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
AstraZeneca
Description
AstraZeneca is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines, particularly in oncology, biopharmaceuticals, and respiratory diseases. The US site emphasizes their commitment to pushing the boundaries of science to deliver life-changing medicines and highlights their impact in the US market.
Key services
Medicines development and commercialization, Patient support programs, Healthcare provider resources, Community impact and sustainability initiatives
Content quality
excellent
Branding
consistent

Technology

Stack
JavaScript, jQuery, Adobe Analytics, Tealium, CookieReports, Helix RUM, Amazon Web Services (Elastic Load Balancing), VMware
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data in HTML
  • Use of reputable analytics and tag management tools

Analytics and tracking

Services
Adobe Analytics, Tealium
Tracking level
moderate
Privacy practices
good

Advertising

Ad networks
Adobe Media Optimizer
Tracking pixels
Adobe Analytics, Tealium, CookieReports
Marketing tools
Tealium Tag Management, Adobe Analytics
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and professional design.
  2. Strong focus on healthcare and pharmaceutical industry.
  3. Comprehensive privacy and cookie policies with consent mechanisms.
  4. No security or WAF blocking detected.
  5. WHOIS data unavailable, limiting domain registration verification.
  6. Use of multiple reputable third-party analytics and tag management tools.
  7. Social media presence on major platforms is clearly linked.
  8. No exposed sensitive data or obvious vulnerabilities found in HTML content.
Technical notes

Notes

The website is built on a modern technology stack including Adobe Experience Manager CMS, JavaScript libraries like jQuery, and integrates advanced analytics via Adobe Analytics and Tealium. Hosting is provided by Amazon Web Services with Elastic Load Balancing for performance and reliability. The site demonstrates good mobile optimization and accessibility features. Performance is moderate, with potential for improvement through optimization of third-party scripts and image assets. The technical infrastructure supports a professional and scalable digital presence suitable for a large enterprise in the healthcare sector.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with astrazeneca-us.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review astrazeneca-us.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.